Sign Up Today and Learn More About Immuta Stock
Invest in or calculate the value of your shares in Immuta or other pre-IPO companies through EquityZen's platform.
Immuta Stock
Immuta is the market leader in secure Data Access, providing data teams one universal platform to control access to cloud data.
About Immuta Stock
Founded
2015
Headquarters
Boston, MA, US
Notable Investor
Snowflake Ventures
Industries
Immuta provides a cloud-native data governance platform for organizations to automate data access control, security, and privacy compliance, ensuring each user who queries data sees only the data they’re supposed to see, for their approved purpose or role. The platform aims to create trust across data engineering, security, legal, compliance, and business teams so they can work together to ensure timely access to critical data with minimal risk while adhering to global data privacy regulations including the GDPR, CCPA, and HIPAA.
Immuta Press Mentions
Stay in the know about the latest news on Immuta
Systems and methods to enhance privacy through decision tree based suppression …
patents • Apr, 14 2024
Systems and methods for obscuring data from a data source
patents • Apr, 14 2024
Systems and methods for reduction of privacy risk in data
patents • Apr, 14 2024
Calculating differentially private queries using local sensitivity on time …
patents • Apr, 14 2024
Systems and methods for privacy-enhancing modification of a database query
patents • Apr, 14 2024
Investors in Immuta
Discover investors in Immuta stock and explore their portfolio companies
Immuta Management
Leadership team at Immuta
CEO & Founder
Matthew Carroll
Founder & Chief Customer Officer
Michael Schiller
Join now and verify your accreditation status to gain access to:
- Immuta current valuation
- Immuta stock price
- Available deals in Immuta and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Immuta stock?
Accredited investors can buy pre-IPO stock in companies like Immuta through EquityZen funds. These investments are made available by existing Immuta shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Immuta stock?
Shareholders can sell their Immuta stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
